These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 7412711)

  • 21. [Problems related to the radiographic study of the biliary tract using oral or intravenous contrast media. Main side effects and biochemical changes induced by the administration of contrast media].
    Limido G
    Minerva Dietol Gastroenterol; 1984; 30(1):9-15. PubMed ID: 6374500
    [No Abstract]   [Full Text] [Related]  

  • 22. [Use of ceruletide in oral cholecystography].
    Romagnoli U; Ripoli G; Salvatori G
    Radiol Med; 1976 Mar; 62(3):202-15. PubMed ID: 802908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinico-radiological study of 3 radiopaque substances used in oral cholecystography].
    Ipinza I
    Rev Med Chil; 1982 Aug; 110(8):761-5. PubMed ID: 7156610
    [No Abstract]   [Full Text] [Related]  

  • 24. Radiopaque contrast media. XXXVIII - Iopronic acid, a new contrast medium for oral cholecystography: toxicologic investigation.
    Tirone P; Rosati G
    Farmaco Prat; 1976 Sep; 31(9):437-46. PubMed ID: 1010018
    [No Abstract]   [Full Text] [Related]  

  • 25. [Nonvisualized gallbladder in cholecystography per os: radiotomographic study after a second dose].
    Gasparini G; Guzzon A; Lombardi F
    Radiol Med; 1976 Mar; 62(3):216-26. PubMed ID: 1078280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Efficacy of the oral contrast medium Falignost in fractionated cholangio-cholecystography].
    Loreck D
    Radiol Diagn (Berl); 1977; 18(3):359-68. PubMed ID: 905546
    [No Abstract]   [Full Text] [Related]  

  • 27. Use of oral cholecystography agents in the treatment of hyperthyroidism of subacute thyroiditis.
    Martinez DS; Chopra IJ
    Panminerva Med; 2003 Mar; 45(1):53-7. PubMed ID: 12682620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A defect of steady filling of the gallbladder with an unusual cause. Subserosa cyst of the gallbladder wall in a patient with polycycstic degerneration of the liver].
    Pastremoli A; Ferrari G
    Arch Ital Mal Appar Dig; 1968; 35(2):182-90. PubMed ID: 5706409
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparative trial of oral cholecystographic contrast agents.
    Wall JJ
    Radiography; 1972 Jul; 38(451):180-4. PubMed ID: 5070481
    [No Abstract]   [Full Text] [Related]  

  • 30. Radiopaque contrast media. XXXVII-Iopronic acid, a new contrast medium for oral cholecystography: pharmacologic investigation.
    Tirone P; Rosati G
    Farmaco Prat; 1976 Aug; 31(8):397-412. PubMed ID: 955053
    [No Abstract]   [Full Text] [Related]  

  • 31. [On problems of dosage and application for peroral cholecystography with falignost (author's transl)].
    Voigt A
    Radiol Diagn (Berl); 1977; 18(5):673-7. PubMed ID: 607265
    [No Abstract]   [Full Text] [Related]  

  • 32. [New possibilities of peroral biliary tract radiography. Clinical experiences with Falignost].
    Barke R; Hasert V
    Dtsch Gesundheitsw; 1972 Mar; 27(9):397-400. PubMed ID: 5031812
    [No Abstract]   [Full Text] [Related]  

  • 33. [Results and conclusions from metabolic studies of I 131 -falignost].
    Barke R; Hieckel HG
    Radiol Diagn (Berl); 1972; 13(6):805-15. PubMed ID: 4657544
    [No Abstract]   [Full Text] [Related]  

  • 34. [Pulmonary edema after administration of peroral biliary contrast media].
    Scheinert H; Torjussen B
    Tidsskr Nor Laegeforen; 1985 Mar; 105(9-10):674-6. PubMed ID: 3992559
    [No Abstract]   [Full Text] [Related]  

  • 35. Conventional oral cholecystography versus single-visit oral cholecystography.
    Nathan MH; Newman A
    Am J Gastroenterol; 1981 Dec; 76(6):527-9. PubMed ID: 7331984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical trial of bilopaque (tyropanoate sodium) oral cholecystography. Evaluation of time for the optimal and peak opacification of the gallbladder.
    Han SY; Witten DM
    Radiology; 1974 Sep; 112(3):529-30. PubMed ID: 4843280
    [No Abstract]   [Full Text] [Related]  

  • 37. Single dose oral cholecystography.
    Krook PM; Bush WH
    Radiology; 1978 Jun; 127(3):643-4. PubMed ID: 663149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparative appraisal of different methods of contrasting the bile outflow system].
    Lisitsyn KM; Severova NS; Vorotnikova RP
    Vestn Khir Im I I Grek; 1973 Dec; 111(12):32-4. PubMed ID: 4785818
    [No Abstract]   [Full Text] [Related]  

  • 39. Conjugated sodium tyropanoate (Bilopaque) in the bowel: significance of its presence or absence after first-dose oral cholecystography.
    Muhletaler CA; Gerlock AJ; Avant GR
    Radiology; 1981 Nov; 141(2):311-6. PubMed ID: 7291552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Physiological or pathological value of prolonged persistence of gallbladder opacification after oral cholecystography (author's transl)].
    Dayras M; Buchet R
    J Radiol Electrol Med Nucl; 1974 Apr; 55(4):289-95. PubMed ID: 4427299
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.